APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptic Ulcer Drugs

A peptic ulcer is a round or oval sore where the lining of the stomach or duodenum has been eaten away by stomach acid and digestive juices. Peptic ulcers can result from Helicobacter pylori infection or from drugs that weaken the lining of the stomach or duodenum. This report mainly studies Peptic Ulcer Drugs market.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A peptic ulcer is a round or oval sore where the lining of the stomach or duodenum has been eaten away by stomach acid and digestive juices. Peptic ulcers can result from Helicobacter pylori infection or from drugs that weaken the lining of the stomach or duodenum. This report mainly studies Peptic Ulcer Drugs market.

Selected research

Industry Growth & Trends

Global Peptic Ulcer Drugs Industry Growth and Trends Forecast to 2032

26 December 2025100 pages

Choose your research edition.

Industry ResearchPeptic Ulcer Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptic Ulcer Drugs Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Peptic Ulcer Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptic Ulcer Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptic Ulcer Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

A peptic ulcer is a round or oval sore where the lining of the stomach or duodenum has been eaten away by stomach acid and digestive juices. Peptic ulcers can result from Helicobacter pylori infection or from drugs that weaken the lining of the stomach or duodenum. This report mainly studies Peptic Ulcer Drugs market.

The main global Peptic Ulcer Drugs players include Takeda Pharmaceutical, AstraZeneca, Pfizer, Teva Pharmaceuticals, EA Pharma, etc. The top five Peptic Ulcer Drugs players account for approximately 43% of the total market. United States is the largest consumer market for Peptic Ulcer Drugs, accounting for about 30%, followed by Europe and China. In terms of type, Proton Pump Inhibitors is the largest segment, with a share over 68%. And in terms of application, the largest application is Hospital and Clinic, followed by Drugstore.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Peptic Ulcer Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Peptic Ulcer Drugs market size, estimates, and forecasts are presented in terms of sales volume (M Unit) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peptic Ulcer Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peptic Ulcer Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Peptic Ulcer Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Peptic Ulcer Drugs Market by Company

Takeda Pharmaceutical

AstraZeneca

Pfizer

Teva Pharmaceuticals

EA Pharma

ASK Pharm

Luoxin Pharmaceutical

Abbott Laboratories

Yuhan Pharmaceutical

Daewoong Pharmaceutical

Peptic Ulcer Drugs Segment by Type

Proton Pump Inhibitors

H2-Antagonists

Antacids

Others

Peptic Ulcer Drugs Segment by Application

Hospital and Clinic

Drugstore

Peptic Ulcer Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptic Ulcer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptic Ulcer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptic Ulcer Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peptic Ulcer Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Peptic Ulcer Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Proton Pump Inhibitors Table 2. Major Company of H2-Antagonists Table 3. Major Company of Antacids Table 4. Major Company of Others Table 5. Global Peptic Ulcer Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Peptic Ulcer Drugs Sales by Type (2021-2026) & (M Unit) Table 7. Global Peptic Ulcer Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Peptic Ulcer Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Peptic Ulcer Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Peptic Ulcer Drugs Price by Type (2021-2026) & (USD/K Units) Table 11. Global Peptic Ulcer Drugs Sales by Type (2027-2032) & (M Unit) Table 12. Global Peptic Ulcer Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Peptic Ulcer Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Peptic Ulcer Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Peptic Ulcer Drugs Price by Type (2027-2032) & (USD/K Units) Table 16. North America Peptic Ulcer Drugs Sales by Type (2021-2026) & (M Unit) Table 17. North America Peptic Ulcer Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Peptic Ulcer Drugs Sales by Type (2021-2026) & (M Unit) Table 19. Europe Peptic Ulcer Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Peptic Ulcer Drugs Sales by Type (2021-2026) & (M Unit) Table 21. Asia-Pacific Peptic Ulcer Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Peptic Ulcer Drugs Sales by Type (2021-2026) & (M Unit) Table 23. Latin America Peptic Ulcer Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Peptic Ulcer Drugs Sales by Type (2021-2026) & (M Unit) Table 25. Middle East and Africa Peptic Ulcer Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Peptic Ulcer Drugs Industry Trends Table 27. Peptic Ulcer Drugs Industry Drivers Table 28. Peptic Ulcer Drugs Industry Opportunities and Challenges Table 29. Peptic Ulcer Drugs Industry Restraints Table 30. Global Peptic Ulcer Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Peptic Ulcer Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Peptic Ulcer Drugs Sales by Company (2021-2026) & (M Unit) Table 33. Global Peptic Ulcer Drugs Sales Share by Company (2021-2026) Table 34. Global Peptic Ulcer Drugs Market Price by Company (2021-2026) & (USD/K Units) Table 35. Global Peptic Ulcer Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Peptic Ulcer Drugs Major Company Production Sites and Headquarters Table 37. Global Peptic Ulcer Drugs Company, Product Type & Application Table 38. Global Peptic Ulcer Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Peptic Ulcer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Peptic Ulcer Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Peptic Ulcer Drugs Sales by Region (2021-2026) & (M Unit) Table 43. Global Peptic Ulcer Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Peptic Ulcer Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Peptic Ulcer Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Peptic Ulcer Drugs Sales (M Unit), Value (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 47. Global Peptic Ulcer Drugs Sales by Region (2027-2032) & (M Unit) Table 48. Global Peptic Ulcer Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Peptic Ulcer Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Peptic Ulcer Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Peptic Ulcer Drugs Sales (M Unit), Value (US$ Million), Price (USD/K Units) and Gross Margin (2027-2032) Table 52. Global Peptic Ulcer Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Peptic Ulcer Drugs Sales by Application (2021-2026) & (M Unit) Table 54. Global Peptic Ulcer Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Peptic Ulcer Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Peptic Ulcer Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Peptic Ulcer Drugs Price by Application (2021-2026) & (USD/K Units) Table 58. Global Peptic Ulcer Drugs Sales by Application (2027-2032) & (M Unit) Table 59. Global Peptic Ulcer Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Peptic Ulcer Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Peptic Ulcer Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Peptic Ulcer Drugs Price by Application (2027-2032) & (USD/K Units) Table 63. North America Peptic Ulcer Drugs Sales by Application (2021-2026) & (M Unit) Table 64. North America Peptic Ulcer Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Peptic Ulcer Drugs Sales by Application (2021-2026) & (M Unit) Table 66. Europe Peptic Ulcer Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Peptic Ulcer Drugs Sales by Application (2021-2026) & (M Unit) Table 68. Asia-Pacific Peptic Ulcer Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Peptic Ulcer Drugs Sales by Application (2021-2026) & (M Unit) Table 70. Latin America Peptic Ulcer Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Peptic Ulcer Drugs Sales by Application (2021-2026) & (M Unit) Table 72. Middle East and Africa Peptic Ulcer Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Takeda Pharmaceutical Company Information Table 74. Takeda Pharmaceutical Business Overview Table 75. Takeda Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 76. Takeda Pharmaceutical Peptic Ulcer Drugs Product Portfolio Table 77. Takeda Pharmaceutical Recent Development Table 78. AstraZeneca Company Information Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 81. AstraZeneca Peptic Ulcer Drugs Product Portfolio Table 82. AstraZeneca Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 86. Pfizer Peptic Ulcer Drugs Product Portfolio Table 87. Pfizer Recent Development Table 88. Teva Pharmaceuticals Company Information Table 89. Teva Pharmaceuticals Business Overview Table 90. Teva Pharmaceuticals Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 91. Teva Pharmaceuticals Peptic Ulcer Drugs Product Portfolio Table 92. Teva Pharmaceuticals Recent Development Table 93. EA Pharma Company Information Table 94. EA Pharma Business Overview Table 95. EA Pharma Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 96. EA Pharma Peptic Ulcer Drugs Product Portfolio Table 97. EA Pharma Recent Development Table 98. ASK Pharm Company Information Table 99. ASK Pharm Business Overview Table 100. ASK Pharm Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 101. ASK Pharm Peptic Ulcer Drugs Product Portfolio Table 102. ASK Pharm Recent Development Table 103. Luoxin Pharmaceutical Company Information Table 104. Luoxin Pharmaceutical Business Overview Table 105. Luoxin Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 106. Luoxin Pharmaceutical Peptic Ulcer Drugs Product Portfolio Table 107. Luoxin Pharmaceutical Recent Development Table 108. Abbott Laboratories Company Information Table 109. Abbott Laboratories Business Overview Table 110. Abbott Laboratories Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 111. Abbott Laboratories Peptic Ulcer Drugs Product Portfolio Table 112. Abbott Laboratories Recent Development Table 113. Yuhan Pharmaceutical Company Information Table 114. Yuhan Pharmaceutical Business Overview Table 115. Yuhan Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 116. Yuhan Pharmaceutical Peptic Ulcer Drugs Product Portfolio Table 117. Yuhan Pharmaceutical Recent Development Table 118. Daewoong Pharmaceutical Company Information Table 119. Daewoong Pharmaceutical Business Overview Table 120. Daewoong Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 121. Daewoong Pharmaceutical Peptic Ulcer Drugs Product Portfolio Table 122. Daewoong Pharmaceutical Recent Development Table 123. North America Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 124. North America Peptic Ulcer Drugs Sales by Country (2021-2026) & (M Unit) Table 125. North America Peptic Ulcer Drugs Sales Market Share by Country (2021-2026) Table 126. North America Peptic Ulcer Drugs Sales Forecast by Country (2027-2032) & (M Unit) Table 127. North America Peptic Ulcer Drugs Sales Market Share Forecast by Country (2027-2032) Table 128. North America Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Peptic Ulcer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Peptic Ulcer Drugs Market Share by Country (2021-2026) Table 131. North America Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Peptic Ulcer Drugs Market Share Forecast by Country (2027-2032) Table 133. Europe Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 134. Europe Peptic Ulcer Drugs Sales by Country (2021-2026) & (M Unit) Table 135. Europe Peptic Ulcer Drugs Sales Market Share by Country (2021-2026) Table 136. Europe Peptic Ulcer Drugs Sales Forecast by Country (2027-2032) & (M Unit) Table 137. Europe Peptic Ulcer Drugs Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Peptic Ulcer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Peptic Ulcer Drugs Market Share by Country (2021-2026) Table 141. Europe Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Peptic Ulcer Drugs Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Peptic Ulcer Drugs Sales by Country (2021-2026) & (M Unit) Table 145. Asia-Pacific Peptic Ulcer Drugs Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Peptic Ulcer Drugs Sales Forecast by Country (2027-2032) & (M Unit) Table 147. Asia-Pacific Peptic Ulcer Drugs Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Peptic Ulcer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Peptic Ulcer Drugs Market Share by Country (2021-2026) Table 151. Asia-Pacific Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Peptic Ulcer Drugs Market Share Forecast by Country (2027-2032) Table 153. Latin America Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 154. Latin America Peptic Ulcer Drugs Sales by Country (2021-2026) & (M Unit) Table 155. Latin America Peptic Ulcer Drugs Sales Market Share by Country (2021-2026) Table 156. Latin America Peptic Ulcer Drugs Sales Forecast by Country (2027-2032) & (M Unit) Table 157. Latin America Peptic Ulcer Drugs Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Peptic Ulcer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Peptic Ulcer Drugs Market Share by Country (2021-2026) Table 161. Latin America Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Peptic Ulcer Drugs Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Peptic Ulcer Drugs Sales by Country (2021-2026) & (M Unit) Table 165. Middle East and Africa Peptic Ulcer Drugs Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Peptic Ulcer Drugs Sales Forecast by Country (2027-2032) & (M Unit) Table 167. Middle East and Africa Peptic Ulcer Drugs Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Peptic Ulcer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Peptic Ulcer Drugs Market Share by Country (2021-2026) Table 171. Middle East and Africa Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Peptic Ulcer Drugs Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Peptic Ulcer Drugs Distributors List Table 176. Peptic Ulcer Drugs Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Peptic Ulcer Drugs Image Figure 2. Global Peptic Ulcer Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peptic Ulcer Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Peptic Ulcer Drugs Sales (2021-2032) & (M Unit) Figure 5. Proton Pump Inhibitors Image Figure 6. Global Proton Pump Inhibitors Sales YoY Growth (2021-2032) & (M Unit) Figure 7. H2-Antagonists Image Figure 8. Global H2-Antagonists Sales YoY Growth (2021-2032) & (M Unit) Figure 9. Antacids Image Figure 10. Global Antacids Sales YoY Growth (2021-2032) & (M Unit) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (M Unit) Figure 13. Global Peptic Ulcer Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Peptic Ulcer Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Peptic Ulcer Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Peptic Ulcer Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Peptic Ulcer Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Peptic Ulcer Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Peptic Ulcer Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Peptic Ulcer Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Peptic Ulcer Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Peptic Ulcer Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Peptic Ulcer Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Peptic Ulcer Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Peptic Ulcer Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital and Clinic Image Figure 28. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (M Unit) Figure 29. Drugstore Image Figure 30. Global Drugstore Sales YoY Growth (2021-2032) & (M Unit) Figure 31. Global Peptic Ulcer Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Peptic Ulcer Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Peptic Ulcer Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Peptic Ulcer Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Peptic Ulcer Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Peptic Ulcer Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Peptic Ulcer Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Peptic Ulcer Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Peptic Ulcer Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Peptic Ulcer Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Peptic Ulcer Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Peptic Ulcer Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Peptic Ulcer Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 44. North America Peptic Ulcer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Peptic Ulcer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Peptic Ulcer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Peptic Ulcer Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 48. Europe Peptic Ulcer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Peptic Ulcer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Peptic Ulcer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Peptic Ulcer Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 52. Asia-Pacific Peptic Ulcer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Peptic Ulcer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Peptic Ulcer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Peptic Ulcer Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 56. Latin America Peptic Ulcer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Peptic Ulcer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Peptic Ulcer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Peptic Ulcer Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 60. Middle East and Africa Peptic Ulcer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Peptic Ulcer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Peptic Ulcer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Peptic Ulcer Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Peptic Ulcer Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Proton Pump Inhibitors
  • H2-Antagonists
  • Antacids
  • Others
Applications
  • Hospital and Clinic
  • Drugstore
Companies covered
  • Takeda Pharmaceutical
  • AstraZeneca
  • Pfizer
  • Teva Pharmaceuticals
  • EA Pharma
  • ASK Pharm
  • Luoxin Pharmaceutical
  • Abbott Laboratories
  • Yuhan Pharmaceutical
  • Daewoong Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Peptic Ulcer Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Peptic Ulcer Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Peptic Ulcer Drugs Market by Type
  6. 1.3.1 Proton Pump Inhibitors
  7. 1.3.2 H2-Antagonists
  8. 1.3.3 Antacids
  9. 1.3.4 Others
  10. 1.4 Global Peptic Ulcer Drugs Market Size by Type
  11. 1.4.1 Global Peptic Ulcer Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Peptic Ulcer Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Peptic Ulcer Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Peptic Ulcer Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Peptic Ulcer Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Peptic Ulcer Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Peptic Ulcer Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Peptic Ulcer Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Peptic Ulcer Drugs Industry Trends
  2. 2.2 Peptic Ulcer Drugs Industry Drivers
  3. 2.3 Peptic Ulcer Drugs Industry Opportunities and Challenges
  4. 2.4 Peptic Ulcer Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Peptic Ulcer Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Peptic Ulcer Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Peptic Ulcer Drugs Price (2021-2026)
  4. 3.4 Global Peptic Ulcer Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Peptic Ulcer Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Peptic Ulcer Drugs Company, Product Type & Application
  7. 3.7 Global Peptic Ulcer Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Peptic Ulcer Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Peptic Ulcer Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Peptic Ulcer Drugs Tier 1, Tier 2, and Tier 3
4 Peptic Ulcer Drugs Regional Status and Outlook
  1. 4.1 Global Peptic Ulcer Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Peptic Ulcer Drugs Historic Market Size by Region
  3. 4.2.1 Global Peptic Ulcer Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Peptic Ulcer Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Peptic Ulcer Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Peptic Ulcer Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Peptic Ulcer Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Peptic Ulcer Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Peptic Ulcer Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Peptic Ulcer Drugs by Application
  1. 5.1 Peptic Ulcer Drugs Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Drugstore
  4. 5.2 Global Peptic Ulcer Drugs Market Size by Application
  5. 5.2.1 Global Peptic Ulcer Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Peptic Ulcer Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Peptic Ulcer Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Peptic Ulcer Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Peptic Ulcer Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Peptic Ulcer Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Peptic Ulcer Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Peptic Ulcer Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical
  2. 6.1.1 Takeda Pharmaceutical Company Information
  3. 6.1.2 Takeda Pharmaceutical Business Overview
  4. 6.1.3 Takeda Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Peptic Ulcer Drugs Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Recent Developments
  7. 6.2 AstraZeneca
  8. 6.2.1 AstraZeneca Company Information
  9. 6.2.2 AstraZeneca Business Overview
  10. 6.2.3 AstraZeneca Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca Peptic Ulcer Drugs Product Portfolio
  12. 6.2.5 AstraZeneca Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Peptic Ulcer Drugs Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Teva Pharmaceuticals
  20. 6.4.1 Teva Pharmaceuticals Company Information
  21. 6.4.2 Teva Pharmaceuticals Business Overview
  22. 6.4.3 Teva Pharmaceuticals Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teva Pharmaceuticals Peptic Ulcer Drugs Product Portfolio
  24. 6.4.5 Teva Pharmaceuticals Recent Developments
  25. 6.5 EA Pharma
  26. 6.5.1 EA Pharma Company Information
  27. 6.5.2 EA Pharma Business Overview
  28. 6.5.3 EA Pharma Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 EA Pharma Peptic Ulcer Drugs Product Portfolio
  30. 6.5.5 EA Pharma Recent Developments
  31. 6.6 ASK Pharm
  32. 6.6.1 ASK Pharm Company Information
  33. 6.6.2 ASK Pharm Business Overview
  34. 6.6.3 ASK Pharm Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 ASK Pharm Peptic Ulcer Drugs Product Portfolio
  36. 6.6.5 ASK Pharm Recent Developments
  37. 6.7 Luoxin Pharmaceutical
  38. 6.7.1 Luoxin Pharmaceutical Company Information
  39. 6.7.2 Luoxin Pharmaceutical Business Overview
  40. 6.7.3 Luoxin Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Luoxin Pharmaceutical Peptic Ulcer Drugs Product Portfolio
  42. 6.7.5 Luoxin Pharmaceutical Recent Developments
  43. 6.8 Abbott Laboratories
  44. 6.8.1 Abbott Laboratories Company Information
  45. 6.8.2 Abbott Laboratories Business Overview
  46. 6.8.3 Abbott Laboratories Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Abbott Laboratories Peptic Ulcer Drugs Product Portfolio
  48. 6.8.5 Abbott Laboratories Recent Developments
  49. 6.9 Yuhan Pharmaceutical
  50. 6.9.1 Yuhan Pharmaceutical Company Information
  51. 6.9.2 Yuhan Pharmaceutical Business Overview
  52. 6.9.3 Yuhan Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Yuhan Pharmaceutical Peptic Ulcer Drugs Product Portfolio
  54. 6.9.5 Yuhan Pharmaceutical Recent Developments
  55. 6.10 Daewoong Pharmaceutical
  56. 6.10.1 Daewoong Pharmaceutical Company Information
  57. 6.10.2 Daewoong Pharmaceutical Business Overview
  58. 6.10.3 Daewoong Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Daewoong Pharmaceutical Peptic Ulcer Drugs Product Portfolio
  60. 6.10.5 Daewoong Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Peptic Ulcer Drugs Sales by Country
  2. 7.1.1 North America Peptic Ulcer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Peptic Ulcer Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Peptic Ulcer Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Peptic Ulcer Drugs Market Size by Country
  6. 7.2.1 North America Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Peptic Ulcer Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Peptic Ulcer Drugs Sales by Country
  2. 8.1.1 Europe Peptic Ulcer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Peptic Ulcer Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Peptic Ulcer Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Peptic Ulcer Drugs Market Size by Country
  6. 8.2.1 Europe Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Peptic Ulcer Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Peptic Ulcer Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Peptic Ulcer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Peptic Ulcer Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Peptic Ulcer Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Peptic Ulcer Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Peptic Ulcer Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Peptic Ulcer Drugs Sales by Country
  2. 10.1.1 South America Peptic Ulcer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Peptic Ulcer Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Peptic Ulcer Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Peptic Ulcer Drugs Market Size by Country
  6. 10.2.1 South America Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Peptic Ulcer Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Peptic Ulcer Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Peptic Ulcer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Peptic Ulcer Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Peptic Ulcer Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Peptic Ulcer Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Peptic Ulcer Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Peptic Ulcer Drugs Value Chain Analysis
  2. 12.1.1 Peptic Ulcer Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Peptic Ulcer Drugs Production Mode & Process
  7. 12.2 Peptic Ulcer Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Peptic Ulcer Drugs Distributors
  10. 12.2.3 Peptic Ulcer Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst